Identification of predictors of metastatic potential in paragangliomas to develop a prognostic score (PSPGL)
Publication Details
Iguchi, D. Y.,
Fhilho, S. N.,
Soares, I. C.,
Siqueria, S. A.,
Alves, V. A.,
Assato, A. K.,
Yang, J. H.,
Almeida, M. Q.,
Fragoso, M. C.,
Fagundes, G. F.,
Mendonca, B. B.,
Junior, D. M.,
Hoff, A. O.,
Castroneves, L. A.,
Ferraz-de-Souza, B.,
Giannella, M. L.,
&
Pereira, M. A.
(2024).
Identification of predictors of metastatic potential in paragangliomas to develop a prognostic score (PSPGL).
Journal of the Endocrine Society, 8 (7).
Abstract
Context: Paragangliomas (PGLs) are rare tumors in adrenal and extra-adrenal locations. Metastasis are found in approximately 5% to 35% of PGLs, and there are no reliable predictors of metastatic disease.
Objective: This work aimed to develop a prognostic score of metastatic potential in PGLs.
Methods: A retrospective analysis was conducted of clinical data from a cohort with PGLs and tumor histological assessment. Patients were divided into metastatic PGL (presence of metastasis) and nonmetastatic PGL (absence of metastasis ≥96 months of follow-up) groups. Univariate and multivariable analysis were performed to identify predictors of metastatic potential. A prognostic score was developed based on coefficients of multivariable analysis. Kaplan-Meier curves were generated to estimate disease-specific survival (DSS).
Results: Out of 263 patients, 35 patients had metastatic PGL and 110 patients had nonmetastatic PGL. In multivariable analysis, 4 features were independently related to metastatic disease and composed the Prognostic Score of Paragangliomas (PSPGL): presence of central or confluent necrosis (33 points), more than 3 mitosis/10 high-power field (HPF) (28 points), extension into adipose tissue (20 points), and extra-adrenal location (19 points). A PSPGL of 24 or greater showed similar sensitivity with higher specificity than the Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) and Grading System for Adrenal Pheochromocytoma and Paraganglioma (GAPP). PSPGL less than or equal to 20 was associated with a risk of metastasis of approximately 10%, whereas a PSPGL of 40 or greater was associated with approximately 80%. The presence of metastasis and Ki-67 of 3% or greater were related to lower DSS.
Conclusion: The PSPGL, composed of 4 easy-to-assess parameters, demonstrated good performance in predicting metastatic potential and good ability in estimating metastasis risk.
Keywords
paraganglioma, pheochromocytoma, metastatic paraganglioma, non-metastatic paraganglioma, PASS, GAPP
Link to Publisher Version (URL)
